Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In
Jane Sarashon
APRIL 8, 2024
As Donovan notes, “GLP-1 medication is not cheap if purchased by a private individual,” estimating that only one in five adults has insurance that would cover anti-obesity medication. In 2023 and 2924, obesity met its match quoting from the Science magazine cover lauding weight loss drugs as breakthrough of the year.
Let's personalize your content